<?xml version="1.0" encoding="UTF-8"?>
<p id="Par40">Some treatments have been adopted in clinical practice, and a few have been successful [
 <xref ref-type="bibr" rid="CR24">24</xref>, 
 <xref ref-type="bibr" rid="CR47">47</xref>]. According to Prashant Pradhan, the first case cured in seven days in the United States showed that the antiviral medication remdesivir may become one of the specific medicines for COVID-19; however, this remains to be verified through clinical trials [
 <xref ref-type="bibr" rid="CR16">16</xref>]. According to the research by Wang, XF, et al. about the clinical manifestations and epidemiology in children with COVID-19 treated with lopinavir and ritonavir and without glucocorticoids and immunoglobulin, all 20 patients improved and were discharged from hospital. This may lead to the conclusion that children’s clinical symptoms of COVID-19 are nonspecific and milder than those in adults, which has significant clinical value [
 <xref ref-type="bibr" rid="CR48">48</xref>].
</p>
